17.9M
XNAS Volume
High volume today
XNAS 18 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Jeffrey A. Meckler | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 1.18 per share. | 25 Nov 2024 | 42,553 | 202,859 | - | 1.2 | 50,000 | Common stock |
| Jeffrey A. Meckler | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2024 | 42,553 | 42,553 | - | - | Common Stock Warrants | |
| Michael J. Newman | Director, CSO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Roger J. Waltzman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Nir Sassi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Walt A. Linscott | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey A. Meckler | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey A. Meckler | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 84,932 | 84,932 | - | - | Common Stock Warrants | |
| Jeffrey A. Meckler | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 1.83 per share. | 08 Aug 2024 | 84,932 | 160,306 | - | 1.8 | 155,001 | Common stock |
| Hila Karah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| William Bradley Hayes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Robert E. Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Anthony J. Maddaluna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Roger J. Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Mark J. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Roger J. Waltzman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Sassi Nir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Walt A. Linscott | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Newman J. Michael | Director, CSO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 43,250 | 43,250 | - | - | Stock Option (Right to Buy) | |
| Jeffrey A. Meckler | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| William B. Hayes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Hila Karah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Anthony J. Maddaluna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Mark J. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Roger J. Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Robert E. Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey A. Meckler | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Walt A. Linscott | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Nir Sassi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Michael J. Newman | Director, CSO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 43,250 | 43,250 | - | - | Stock Option (Right to Buy) | |
| Jeffrey A. Meckler | Director, CEO and Director | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 18 Nov 2022 | 9,600 | 75,374 | - | 1.9 | 18,240 | Common stock |
| Jeffrey A. Meckler | Director, CEO and Director | Purchase of securities on an exchange or from another person at price $ 1.76 per share. | 18 Nov 2022 | 400 | 65,774 | - | 1.8 | 705 | Common stock |
| Hila Karah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 13,750 | 13,750 | - | - | Stock Option (right to buy) | |
| William B. Hayes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 13,750 | 13,750 | - | - | Stock Option (right to buy) | |
| Anthony J. Maddaluna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 13,750 | 13,750 | - | - | Stock Option (right to buy) | |
| Roger J. Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 81,000 | 81,000 | - | - | Stock Option (right to buy) | |
| Mark J. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 13,750 | 13,750 | - | - | Stock Option (right to buy) | |
| Jeffrey A. Meckler | Director, CEO and Director | Purchase of securities on an exchange or from another person at price $ 2.80 per share. | 08 Sep 2022 | 10,308 | 65,374 | - | 2.8 | 28,862 | Common stock |
| Walt A. Linscott | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 2.62 per share. | 07 Sep 2022 | 150 | 150 | - | 2.6 | 393 | Common stock |
| Jeffrey A. Meckler | Director, CEO and Director | Purchase of securities on an exchange or from another person at price $ 2.57 per share. | 06 Sep 2022 | 8,632 | 55,066 | - | 2.6 | 22,184 | Common stock |
| Jeffrey A. Meckler | Director, CEO and Director | Purchase of securities on an exchange or from another person at price $ 2.44 per share. | 06 Sep 2022 | 1,060 | 46,434 | - | 2.4 | 2,586 | Common stock |
| Jeffrey A. Meckler | Director, CEO and Director | Purchase of securities on an exchange or from another person at price $ 2.63 per share. | 06 Jun 2022 | 19,727 | 45,374 | - | 2.6 | 51,882 | Common stock |
| Nir Sassi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Boyan Litchev | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Boyan Litchev | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 4.10 per share. | 31 Jan 2022 | 50 | 150 | - | 4.1 | 205 | Common Stock |
| Michael J. Newman | Director, CSO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 31 Jan 2022 | 14,130 | 1,368,356 | - | 5.0 | 70,692 | Common Stock |
| Michael J. Newman | Director, CSO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 31 Jan 2022 | 5,870 | 1,382,486 | - | 5.0 | 29,351 | Common Stock |
| Boyan Litchev | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.87 per share. | 31 Jan 2022 | 500 | 1,150 | - | 1.9 | 935 | Common Stock |
| Boyan Litchev | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 4.65 per share. | 31 Jan 2022 | 100 | 100 | - | 4.7 | 465 | Common Stock |
| Boyan Litchev | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.83 per share. | 31 Jan 2022 | 500 | 650 | - | 1.8 | 915 | Common Stock |
| Jeffrey A. Meckler | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Michael J. Newman | Director, CSO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 43,350 | 43,350 | - | - | Stock Option (right to buy) | |
| Walt A. Linscott | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 45,850 | 45,850 | - | - | Stock Option (right to buy) | |
| Mark J. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Jeffrey A. Meckler | Director, CEO and Director | Purchase of securities on an exchange or from another person at price $ 5.82 per share. | 18 Nov 2021 | 11,187 | 25,647 | - | 5.8 | 65,108 | Common Stock |
| Jeffrey A. Meckler | Director, CEO and Director | Purchase of securities on an exchange or from another person at price $ 7.00 per share. | 14 Sep 2021 | 12,000 | 14,460 | - | 7 | 84,000 | Common Stock |
| Hoonmo Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 13,750 | 13,750 | - | - | Stock Option (right to buy) | |
| Michael J. Newman | Director, CSO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 290,000 | 290,000 | - | - | Stock Option (right to buy) | |
| Nir Sassi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Walt A. Linscott | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 210,000 | 210,000 | - | - | Stock Option (right to buy) | |
| Roger J. Pomerantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 41,000 | 41,000 | - | - | Stock Option (right to buy) | |
| Anthony J. Maddaluna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 13,750 | 13,750 | - | - | Stock Option (right to buy) | |
| Jeffrey A. Meckler | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 375,000 | 375,000 | - | - | Stock Option (right to buy) | |
| Hila Karah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 13,750 | 13,750 | - | - | Stock Option (right to buy) | |
| William B. Hayes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 13,750 | 13,750 | - | - | Stock Option (right to buy) |